15 years ago they had already partnered the lysate program with UCLA. The prostate P3 was ready to launch and the present book trial (then as a P2) was already approved for trial by the FDA.
In that 15 years they have advanced one trial, and that has been on enrollment hold 3 tines for who knows how many years. The trial has morphed so many times that the record on CT.gov reads like War and Peace.
Given that this trial is likely not pivotal, it could be another 15 years E en if the drug does work.
Market Data 
Markets 
AI
